Posts tagged Maxim Group


Promising Future For Omeros Corporation (OMER) with Lead Drug Omidria?

Drug maker Omeros Corporation (NASDAQ:OMER) delivered solid results for its earnings report for the first quarter of …

Read more

Gilead Sciences, Inc. (GILD) Under Pressure After Disappointing Q1 Earnings Report; Maxim Weighs In

Days are becoming tough for Gilead Sciences, Inc. (NASDAQ:GILD) as it recently released its 1Q17 …

Read more

4Q Update: Sophiris Bio Inc (SPHS) Gets A Buy From Maxim

Maxim analyst Jason Kolbert was out with a research note on Sophiris Bio Inc (NASDAQ:SPHS), following the …

Read more

Maxim Weighs in on Mast Therapeutics Inc (MSTX) Following Delay in EPIC Trial Data Results for SCD

Maxim analyst Jason McCarthy comments on Mast Therapeutics Inc (NYSEMKT:MSTX) ahead of EPIC study data …

Read more

Maxim Reiterates Buy on Juno Therapeutics Inc as FDA Lifts Clinical Hold on ROCKET

In a research report released today, Maxim analyst Jason McCarthy reiterated a Buy rating on …

Read more

Meeting With Management Causes Maxim Group To Cut Price Target for Galena Biopharma Inc (GALE)

Analyst Jason McCarthy of Maxim Group maintained a Buy rating for Galena Biopharma Inc (NASDAQ:GALE), but decreased his …

Read more

Analysts Shine Light On AEterna Zentaris Inc. (USA) (AEZS) And OraSure Technologies, Inc. (OSUR) Following Recent Developments

Healthcare analysts explain their bullish views on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and OraSure Technologies, …

Read more

Maxim Weighs In on Anavex Life Sciences Corp. (AVXL), Pluristem Therapeutics Inc. (PSTI) Following Orphan Designation and Preclinical Data

Maxim’s healthcare analyst Jason Kolbert weighed in today on two names in his coverage universe, Anavex Life Sciences Corp. …

Read more

Hold the Phone on Biotech: Valeant Pharmaceuticals Intl Inc (VRX) and Gilead Sciences, Inc. (GILD)

While Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Gilead Sciences, Inc. (NASDAQ:GILD) remain biotech giants, they …

Read more

Biotech Beat: Analysts Weigh In on Exelixis, Inc. (EXEL) and Mast Therapeutics Inc (MSTX)

There’s good news all around as Exelixis, Inc. (NASDAQ:EXEL) releases promising data in an attempt …

Read more